Scholarly Index
Giuseppe Procopio
Fondazione IRCCS Istituto Nazionale dei Tumori; 19,849 total citations; 649 total publications; best world rank #24
Fondazione IRCCS Istituto Nazionale dei Tumori
19,849Total citations
649Total publications
52H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Renal cell carcinoma treatment | Lifetime | 319 | IT 24 | 98.51 |
| Cancer Diagnosis and Treatment | Lifetime | 498 | IT 31 | 97.53 |
| Cancer Immunotherapy and Biomarkers | Lifetime | 897 | IT 53 | 98.14 |
| Economic and Financial Impacts of Cancer | Lifetime | 257 | IT 6 | 97.00 |
| Renal and related cancers | Lifetime | 599 | IT 30 | 97.31 |
| Multiple and Secondary Primary Cancers | Lifetime | 465 | IT 36 | 95.59 |
| Renal cell carcinoma treatment | 2021-2025 | 24 | IT 5 | 99.45 |
| Renal and related cancers | 2021-2025 | 32 | IT 7 | 98.49 |
| Cancer Genomics and Diagnostics | 2021-2025 | 151 | IT 13 | 98.87 |
| Cancer Immunotherapy and Biomarkers | 2021-2025 | 481 | IT 32 | 98.11 |
| Prostate Cancer Treatment and Research | 2021-2025 | 261 | IT 18 | 97.35 |
| Cancer Diagnosis and Treatment | 2021-2025 | 128 | IT 11 | 91.45 |
| Bladder and Urothelial Cancer Treatments | 2021-2025 | 361 | IT 61 | 95.69 |
| PARP inhibition in cancer therapy | 2021-2025 | 171 | IT 14 | 94.32 |
| Radiopharmaceutical Chemistry and Applications | 2021-2025 | 648 | IT 33 | 89.09 |
| Multiple and Secondary Primary Cancers | 2021-2025 | 414 | IT 34 | 78.96 |